The GLP is committed to full transparency. Download and review our Annual Report.

China’s approval of 5 GMO crop imports could fuel investment boom in biotech research

| | January 28, 2019

Lost in the news of contentious U.S.-China trade disputes was a meaningful regulatory approval that will improve agriculture around the world.

[In January] Chinese regulators approved the import of five genetically modified crops. These soybean, corn and canola “biotech traits” are designed to grow despite natural obstacles like pest infestation….

This little-noticed agreement will have a big impact on the U.S. agriculture industry. China has accounted for about 60% of total U.S. soy exports, representing $12 billion in trade for American farmers. Those figures may grow; the newly-approved crops will be in high demand.

The agricultural industry must increase investments in biotechnology. New soil-management, crop-protection and seed-enhancement techniques—which promise to make plants more resistant to drought, disease and pests—sometimes take hundreds of millions of dollars to develop and decades to bring to market. The newly-open Chinese market will reward such innovation.

Related article:  In boon to poor farmers, Ghana poised to introduce GMO crops

Any global regulatory system that reviews and ultimately approves these technologies must be science-based. GMO regulatory processes have historically been plagued by politicized disputes which needlessly delay the sale of these vital crops. Hopefully the new agreement with China is a sign that chapter has passed.

Read full, original article: China Opens the Door to U.S. GMOs

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend